Withdrawn trial aimed to save bladders from cancer surgery
NCT ID NCT07342517
Summary
This study planned to test a new bladder cancer treatment called NDV-01 for patients whose cancer returned after standard therapies. The treatment would have been delivered directly into the bladder to try to control the cancer and potentially avoid major surgery. However, the trial was withdrawn before any patients could enroll.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA BLADDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.